TCF founded by Paul Poth after his cholangiocarcinoma diagnosis by Hayden Roberts | Mar 7, 2024To drive more effective and personalized treatments for rare cancers, beginning with an initial grant from Paul to the Massachusetts General Hospital Center for Molecular Therapeutics.